1. Home
  2. ANVS vs KNDI Comparison

ANVS vs KNDI Comparison

Compare ANVS & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • KNDI
  • Stock Information
  • Founded
  • ANVS 2008
  • KNDI 2002
  • Country
  • ANVS United States
  • KNDI China
  • Employees
  • ANVS N/A
  • KNDI N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • KNDI Auto Manufacturing
  • Sector
  • ANVS Health Care
  • KNDI Consumer Discretionary
  • Exchange
  • ANVS Nasdaq
  • KNDI Nasdaq
  • Market Cap
  • ANVS 44.6M
  • KNDI 96.3M
  • IPO Year
  • ANVS 2020
  • KNDI N/A
  • Fundamental
  • Price
  • ANVS $2.75
  • KNDI $1.20
  • Analyst Decision
  • ANVS Strong Buy
  • KNDI
  • Analyst Count
  • ANVS 4
  • KNDI 0
  • Target Price
  • ANVS $18.00
  • KNDI N/A
  • AVG Volume (30 Days)
  • ANVS 437.3K
  • KNDI 109.2K
  • Earning Date
  • ANVS 08-14-2025
  • KNDI 08-15-2025
  • Dividend Yield
  • ANVS N/A
  • KNDI N/A
  • EPS Growth
  • ANVS N/A
  • KNDI N/A
  • EPS
  • ANVS N/A
  • KNDI N/A
  • Revenue
  • ANVS N/A
  • KNDI $127,569,613.00
  • Revenue This Year
  • ANVS N/A
  • KNDI N/A
  • Revenue Next Year
  • ANVS N/A
  • KNDI N/A
  • P/E Ratio
  • ANVS N/A
  • KNDI N/A
  • Revenue Growth
  • ANVS N/A
  • KNDI 3.21
  • 52 Week Low
  • ANVS $1.11
  • KNDI $0.89
  • 52 Week High
  • ANVS $14.80
  • KNDI $2.07
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 57.81
  • KNDI 52.54
  • Support Level
  • ANVS $2.24
  • KNDI $1.09
  • Resistance Level
  • ANVS $2.97
  • KNDI $1.17
  • Average True Range (ATR)
  • ANVS 0.26
  • KNDI 0.07
  • MACD
  • ANVS 0.02
  • KNDI 0.01
  • Stochastic Oscillator
  • ANVS 65.58
  • KNDI 61.23

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.

Share on Social Networks: